ApoA-V
- 1 June 2005
- journal article
- editorial
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 25 (6) , 1097-1099
- https://doi.org/10.1161/01.atv.0000167518.27125.b1
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Transcriptional Regulation of Apolipoprotein A5 Gene Expression by the Nuclear Receptor RORαArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- RORα Regulates the Expression of Genes Involved in Lipid Homeostasis in Skeletal Muscle CellsJournal of Biological Chemistry, 2004
- The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?Current Opinion in Lipidology, 2004
- Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5Biochemical and Biophysical Research Communications, 2004
- The “CholesteROR” Protective Pathway in the Vascular SystemArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Structure and Interfacial Properties of Human Apolipoprotein A-VPublished by Elsevier ,2003
- The Human Apolipoprotein AV Gene Is Regulated by Peroxisome Proliferator-activated Receptor-α and Contains a Novel Farnesoid X-activated Receptor Response ElementPublished by Elsevier ,2003
- Apolipoprotein A5, a Crucial Determinant of Plasma Triglyceride Levels, Is Highly Responsive to Peroxisome Proliferator-activated Receptor α ActivatorsJournal of Biological Chemistry, 2003
- X-Ray Structure of the hRORα LBD at 1.63 ÅStructure, 2002
- An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative SequencingScience, 2001